Judge In Acetaminophen Autism/ ADHD MDL Denies J&J’s Preemption Motion
NEW YORK — The New York federal judge overseeing the acetaminophen autism spectrum disorder-attention deficit hyperactivity disorder (ASD-ADHD) multidistrict litigation has denied a motion by Johnson & Johnson Consumer Inc. (JJCI...To view the full article, register now.
Already a subscriber? Click here to view full article